SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Teva Neuroscience, Inc. Release: COPAXONE(R) Significantly Reduced Brain Atrophy and Tissue Loss over Five Years in Treatment-Naive Relapsing-Remitting Multiple Sclerosis Patients